Assessment of Anti-inflammatory effect of Azithromycin on kidney donor and potential effect on recipient
Phase 3
Recruiting
- Conditions
- Transplanted kidney function.Chronic kidney disease, stage 5
- Registration Number
- IRCT201606141853N11
- Lead Sponsor
- rology Research Centre, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Alive or cadaveric donor; Sign the inform consent by donor or Family of cadaver
Exclusion criteria:
Allergic components or allergic to various brands of Azithromycin; Severe medical disease like heart, liver, renal, hematological; respiratory, cardiovascular, psychiatric or other problem pre transplantation in donor; Consumption of other medication including Macrolides family; Involvement in additional clinical trials at the same time
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method GFR. Timepoint: 1 day, 2 days, 4 days, 30 days and 90 days after transplantation. Method of measurement: Cockcroft-Gault Equation.
- Secondary Outcome Measures
Name Time Method Complication. Timepoint: 1 day, 2 days, 4 days, 30 days and 90 days after transplantation. Method of measurement: Registration of physical examination, medical history and paraclinical findings.;Pain score in donors. Timepoint: 1 day, 2 days and 4 days after transplantation. Method of measurement: Visual Analog Scale (VAS).